LYN kinase, a member of the Src family tyrosine kinases that functions as a pro-oncogene in tumor progression, is reported to be overexpressed in numerous tumors, including CC, chronic myelogenous leukemia, renal cancer, head and neck squamous cell carcinoma, gastric cancer, and prostate cancer [33–37]. The gene discussed is SRC; the disease is prostate carcinoma.